Signal amid noise—quantitative electroencephalography for stratification and early outcome prediction in neonatal hypoxic ischemic encephalopathy

Alexandra Johnson,Courtney J. Wusthoff
DOI: https://doi.org/10.1038/s41390-024-03536-2
IF: 3.953
2024-09-07
Pediatric Research
Abstract:Therapeutic hypothermia is central to the care of newborns with suspected hypoxic-ischemic encephalopathy (HIE). While this treatment has been shown to reduce the risk of subsequent death or disability following moderate-to-severe HIE, it is time-sensitive, requiring prompt and accurate identification of neonates with encephalopathy to initiate treatment within 6 h of birth. Patient identification relies on a combination of clinical and lab markers, relying heavily on the neurological exam. Even as efforts are underway to improve teaching and implementation of the exam to grade encephalopathy, 1,2 there is a need to more quickly and accurately identify at the bedside which newborns might benefit from therapeutic hypothermia. Similarly, to develop new treatments, reproducible early biomarkers for outcomes are critical. EEG is commonly used in neonates with HIE and has been shown to correlate with both the severity of encephalopathy as well as subsequent neurodevelopmental outcomes. 3,4 Conventional electroencephalography (EEG) is resource-intensive, requiring trained technologists to perform recordings. Furthermore, interpretation relies on visual inspection by experienced neurophysiologists, with a delay between recording and interpretation. Reduced-array EEG and amplitude-integrated EEG provide alternatives that are more easily recorded and interpreted, but still typically rely on visual interpretation that is inherently subject to variability and may not precisely predict outcome for many neonates. 5
pediatrics
What problem does this paper attempt to address?